Acute Myeloblastic Leukemia with Maturation

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
Trebananib With or Without Low-Dose Cytarabine in Treating Patients With Acute Myeloid Leukemia
Status:
Completed
Last Changed:
Feb 15, 2017
First Changed:
Mar 15, 2012
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
trebananibcytarabinelaboratory biomarker analysispharmacological study
Decitabine in Treating Children With Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia
Status:
Terminated
Last Changed:
Jan 23, 2013
First Changed:
Jan 27, 2003
Disease(s):
Childhood Acute Myeloblastic Leukemia With Maturation (M2)
Intervention(s):
decitabinepharmacological studylaboratory biomarker analysis
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
Status:
Withdrawn
Last Changed:
May 21, 2018
First Changed:
Apr 18, 2013
Disease(s):
Adult Acute Megakaryoblastic Leukemia (M7)
Intervention(s):
arsenic trioxidelaboratory biomarker analysis

Connect. Empower. Inspire.